Answers are grounded in this paper and cite their sources.
Chronic myeloid leukemia (CML) is a rare disease in childhood. Long-term use of tyrosine kinase inhibitors has become the standard for the treatment of the chronic phase of CML. The article describes the case of development of CML in a child at the age of two years and raised the issue of the need for lifelong drug intake and the problems that arise in connection with this.
No takes yet. Share an insight, caveat, or question.
Yakupova et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: